Patients Being Recruited in Europe to Test Gene Therapy Candidate FLT190 After Promising Preclinical Results
A single injection with candidate gene therapy FLT190 showed positive results in a mouse model of Fabry disease by significantly increasing blood levels of GLA — the enzyme affected in this disease — and reducing Gb3 storage levels in the heart and kidney, the therapy’s developer, Freeline,…